nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—SCN10A—breast cancer	0.656	1	CbGaD
Phenazopyridine—SCN7A—adipose tissue—breast cancer	0.00141	0.0637	CbGeAlD
Phenazopyridine—SCN7A—female reproductive system—breast cancer	0.00129	0.0585	CbGeAlD
Phenazopyridine—SCN7A—adrenal gland—breast cancer	0.00126	0.0571	CbGeAlD
Phenazopyridine—SCN7A—female gonad—breast cancer	0.00118	0.0533	CbGeAlD
Phenazopyridine—SCN9A—pituitary gland—breast cancer	0.00111	0.0501	CbGeAlD
Phenazopyridine—SCN9A—adipose tissue—breast cancer	0.0011	0.0499	CbGeAlD
Phenazopyridine—SCN7A—endocrine gland—breast cancer	0.00109	0.0495	CbGeAlD
Phenazopyridine—SCN9A—adrenal gland—breast cancer	0.000988	0.0447	CbGeAlD
Phenazopyridine—SCN4A—pituitary gland—breast cancer	0.000987	0.0447	CbGeAlD
Phenazopyridine—SCN4A—adipose tissue—breast cancer	0.000983	0.0445	CbGeAlD
Phenazopyridine—SCN8A—endocrine gland—breast cancer	0.000975	0.0441	CbGeAlD
Phenazopyridine—SCN4A—adrenal gland—breast cancer	0.000882	0.0399	CbGeAlD
Phenazopyridine—SCN2A—pituitary gland—breast cancer	0.000873	0.0395	CbGeAlD
Phenazopyridine—SCN10A—pituitary gland—breast cancer	0.000842	0.0381	CbGeAlD
Phenazopyridine—Hepatitis—Melphalan—breast cancer	0.00077	0.00523	CcSEcCtD
Phenazopyridine—SCN3A—pituitary gland—breast cancer	0.000768	0.0347	CbGeAlD
Phenazopyridine—SCN3A—adipose tissue—breast cancer	0.000765	0.0346	CbGeAlD
Phenazopyridine—Visual impairment—Tamoxifen—breast cancer	0.000758	0.00514	CcSEcCtD
Phenazopyridine—SCN7A—lymph node—breast cancer	0.000756	0.0342	CbGeAlD
Phenazopyridine—Hepatitis—Goserelin—breast cancer	0.000752	0.0051	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Ixabepilone—breast cancer	0.000749	0.00508	CcSEcCtD
Phenazopyridine—Pruritus—Fulvestrant—breast cancer	0.000749	0.00508	CcSEcCtD
Phenazopyridine—Pruritus—Toremifene—breast cancer	0.000739	0.00501	CcSEcCtD
Phenazopyridine—Vomiting—Lapatinib—breast cancer	0.000732	0.00496	CcSEcCtD
Phenazopyridine—Rash—Lapatinib—breast cancer	0.000726	0.00492	CcSEcCtD
Phenazopyridine—Dermatitis—Lapatinib—breast cancer	0.000725	0.00492	CcSEcCtD
Phenazopyridine—Diarrhoea—Fulvestrant—breast cancer	0.000724	0.00491	CcSEcCtD
Phenazopyridine—Headache—Lapatinib—breast cancer	0.000721	0.00489	CcSEcCtD
Phenazopyridine—Dyspepsia—Anastrozole—breast cancer	0.000719	0.00488	CcSEcCtD
Phenazopyridine—Dyspepsia—Letrozole—breast cancer	0.000719	0.00488	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Letrozole—breast cancer	0.000705	0.00478	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Anastrozole—breast cancer	0.000705	0.00478	CcSEcCtD
Phenazopyridine—SCN3A—female reproductive system—breast cancer	0.000703	0.0318	CbGeAlD
Phenazopyridine—Jaundice—Thiotepa—breast cancer	0.000698	0.00473	CcSEcCtD
Phenazopyridine—Visual disturbance—Paclitaxel—breast cancer	0.000691	0.00468	CcSEcCtD
Phenazopyridine—SCN3A—adrenal gland—breast cancer	0.000686	0.031	CbGeAlD
Phenazopyridine—Nausea—Lapatinib—breast cancer	0.000684	0.00464	CcSEcCtD
Phenazopyridine—Dyspepsia—Raloxifene—breast cancer	0.000683	0.00463	CcSEcCtD
Phenazopyridine—Hypersensitivity—Exemestane—breast cancer	0.000677	0.00459	CcSEcCtD
Phenazopyridine—SCN2A—endocrine gland—breast cancer	0.000677	0.0306	CbGeAlD
Phenazopyridine—Vomiting—Fulvestrant—breast cancer	0.000673	0.00456	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Raloxifene—breast cancer	0.000669	0.00454	CcSEcCtD
Phenazopyridine—Rash—Fulvestrant—breast cancer	0.000667	0.00453	CcSEcCtD
Phenazopyridine—Dermatitis—Fulvestrant—breast cancer	0.000667	0.00452	CcSEcCtD
Phenazopyridine—Vomiting—Toremifene—breast cancer	0.000664	0.00451	CcSEcCtD
Phenazopyridine—SCN3A—bone marrow—breast cancer	0.000663	0.03	CbGeAlD
Phenazopyridine—Headache—Fulvestrant—breast cancer	0.000663	0.0045	CcSEcCtD
Phenazopyridine—Rash—Toremifene—breast cancer	0.000659	0.00447	CcSEcCtD
Phenazopyridine—Dermatitis—Toremifene—breast cancer	0.000658	0.00446	CcSEcCtD
Phenazopyridine—Headache—Toremifene—breast cancer	0.000655	0.00444	CcSEcCtD
Phenazopyridine—SCN10A—endocrine gland—breast cancer	0.000652	0.0295	CbGeAlD
Phenazopyridine—Pruritus—Exemestane—breast cancer	0.000651	0.00441	CcSEcCtD
Phenazopyridine—Hypersensitivity—Ixabepilone—breast cancer	0.000639	0.00434	CcSEcCtD
Phenazopyridine—Diarrhoea—Exemestane—breast cancer	0.000629	0.00427	CcSEcCtD
Phenazopyridine—Nausea—Fulvestrant—breast cancer	0.000629	0.00426	CcSEcCtD
Phenazopyridine—Nausea—Toremifene—breast cancer	0.000621	0.00421	CcSEcCtD
Phenazopyridine—Pruritus—Ixabepilone—breast cancer	0.000614	0.00416	CcSEcCtD
Phenazopyridine—Jaundice—Irinotecan—breast cancer	0.000603	0.00409	CcSEcCtD
Phenazopyridine—Jaundice—Mitoxantrone—breast cancer	0.000603	0.00409	CcSEcCtD
Phenazopyridine—Hypersensitivity—Anastrozole—breast cancer	0.000602	0.00408	CcSEcCtD
Phenazopyridine—Haemolytic anaemia—Capecitabine—breast cancer	0.000595	0.00404	CcSEcCtD
Phenazopyridine—Diarrhoea—Ixabepilone—breast cancer	0.000594	0.00403	CcSEcCtD
Phenazopyridine—SCN9A—lymph node—breast cancer	0.000592	0.0268	CbGeAlD
Phenazopyridine—Visual disturbance—Docetaxel—breast cancer	0.000585	0.00397	CcSEcCtD
Phenazopyridine—Vomiting—Exemestane—breast cancer	0.000585	0.00397	CcSEcCtD
Phenazopyridine—Rash—Exemestane—breast cancer	0.00058	0.00393	CcSEcCtD
Phenazopyridine—Dermatitis—Exemestane—breast cancer	0.000579	0.00393	CcSEcCtD
Phenazopyridine—Pruritus—Anastrozole—breast cancer	0.000578	0.00392	CcSEcCtD
Phenazopyridine—Pruritus—Letrozole—breast cancer	0.000578	0.00392	CcSEcCtD
Phenazopyridine—Headache—Exemestane—breast cancer	0.000576	0.00391	CcSEcCtD
Phenazopyridine—Hypersensitivity—Idarubicin—breast cancer	0.000571	0.00387	CcSEcCtD
Phenazopyridine—Diarrhoea—Letrozole—breast cancer	0.000559	0.00379	CcSEcCtD
Phenazopyridine—Diarrhoea—Anastrozole—breast cancer	0.000559	0.00379	CcSEcCtD
Phenazopyridine—Hepatitis—Mitoxantrone—breast cancer	0.000555	0.00377	CcSEcCtD
Phenazopyridine—Dyspepsia—Chlorambucil—breast cancer	0.000553	0.00375	CcSEcCtD
Phenazopyridine—Vomiting—Ixabepilone—breast cancer	0.000552	0.00374	CcSEcCtD
Phenazopyridine—Rash—Ixabepilone—breast cancer	0.000547	0.00371	CcSEcCtD
Phenazopyridine—Dermatitis—Ixabepilone—breast cancer	0.000547	0.00371	CcSEcCtD
Phenazopyridine—Nausea—Exemestane—breast cancer	0.000546	0.0037	CcSEcCtD
Phenazopyridine—Headache—Ixabepilone—breast cancer	0.000544	0.00369	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Chlorambucil—breast cancer	0.000542	0.00368	CcSEcCtD
Phenazopyridine—Visual impairment—Irinotecan—breast cancer	0.000535	0.00363	CcSEcCtD
Phenazopyridine—Diarrhoea—Idarubicin—breast cancer	0.000531	0.0036	CcSEcCtD
Phenazopyridine—Diarrhoea—Raloxifene—breast cancer	0.000531	0.0036	CcSEcCtD
Phenazopyridine—Vomiting—Anastrozole—breast cancer	0.000519	0.00352	CcSEcCtD
Phenazopyridine—Vomiting—Letrozole—breast cancer	0.000519	0.00352	CcSEcCtD
Phenazopyridine—Nausea—Ixabepilone—breast cancer	0.000515	0.0035	CcSEcCtD
Phenazopyridine—Rash—Letrozole—breast cancer	0.000515	0.00349	CcSEcCtD
Phenazopyridine—Rash—Anastrozole—breast cancer	0.000515	0.00349	CcSEcCtD
Phenazopyridine—Dermatitis—Anastrozole—breast cancer	0.000515	0.00349	CcSEcCtD
Phenazopyridine—Dermatitis—Letrozole—breast cancer	0.000515	0.00349	CcSEcCtD
Phenazopyridine—Headache—Anastrozole—breast cancer	0.000512	0.00347	CcSEcCtD
Phenazopyridine—Headache—Letrozole—breast cancer	0.000512	0.00347	CcSEcCtD
Phenazopyridine—Vomiting—Idarubicin—breast cancer	0.000493	0.00334	CcSEcCtD
Phenazopyridine—Vomiting—Raloxifene—breast cancer	0.000493	0.00334	CcSEcCtD
Phenazopyridine—Dyspepsia—Tamoxifen—breast cancer	0.000492	0.00334	CcSEcCtD
Phenazopyridine—Rash—Raloxifene—breast cancer	0.000489	0.00332	CcSEcCtD
Phenazopyridine—Rash—Idarubicin—breast cancer	0.000489	0.00332	CcSEcCtD
Phenazopyridine—Dermatitis—Raloxifene—breast cancer	0.000488	0.00331	CcSEcCtD
Phenazopyridine—Dermatitis—Idarubicin—breast cancer	0.000488	0.00331	CcSEcCtD
Phenazopyridine—Headache—Raloxifene—breast cancer	0.000486	0.00329	CcSEcCtD
Phenazopyridine—Headache—Idarubicin—breast cancer	0.000486	0.00329	CcSEcCtD
Phenazopyridine—Nausea—Anastrozole—breast cancer	0.000485	0.00329	CcSEcCtD
Phenazopyridine—Nausea—Letrozole—breast cancer	0.000485	0.00329	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Tamoxifen—breast cancer	0.000483	0.00327	CcSEcCtD
Phenazopyridine—Dyspepsia—Melphalan—breast cancer	0.000482	0.00327	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Melphalan—breast cancer	0.000473	0.00321	CcSEcCtD
Phenazopyridine—Dyspepsia—Goserelin—breast cancer	0.00047	0.00319	CcSEcCtD
Phenazopyridine—Hypersensitivity—Chlorambucil—breast cancer	0.000463	0.00314	CcSEcCtD
Phenazopyridine—Nausea—Raloxifene—breast cancer	0.000461	0.00312	CcSEcCtD
Phenazopyridine—Nausea—Idarubicin—breast cancer	0.000461	0.00312	CcSEcCtD
Phenazopyridine—SCN10A—lymph node—breast cancer	0.000451	0.0204	CbGeAlD
Phenazopyridine—Pruritus—Chlorambucil—breast cancer	0.000444	0.00301	CcSEcCtD
Phenazopyridine—Visual impairment—Paclitaxel—breast cancer	0.000436	0.00296	CcSEcCtD
Phenazopyridine—Diarrhoea—Chlorambucil—breast cancer	0.00043	0.00291	CcSEcCtD
Phenazopyridine—Hypersensitivity—Vinblastine—breast cancer	0.000424	0.00288	CcSEcCtD
Phenazopyridine—Visual disturbance—Methotrexate—breast cancer	0.000422	0.00286	CcSEcCtD
Phenazopyridine—Jaundice—Docetaxel—breast cancer	0.000417	0.00283	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Vinorelbine—breast cancer	0.000413	0.0028	CcSEcCtD
Phenazopyridine—Hypersensitivity—Tamoxifen—breast cancer	0.000412	0.00279	CcSEcCtD
Phenazopyridine—SCN3A—lymph node—breast cancer	0.000411	0.0186	CbGeAlD
Phenazopyridine—Jaundice—Capecitabine—breast cancer	0.000403	0.00274	CcSEcCtD
Phenazopyridine—Hypersensitivity—Melphalan—breast cancer	0.000403	0.00274	CcSEcCtD
Phenazopyridine—Dyspepsia—Thiotepa—breast cancer	0.000402	0.00273	CcSEcCtD
Phenazopyridine—Vomiting—Chlorambucil—breast cancer	0.000399	0.00271	CcSEcCtD
Phenazopyridine—Pruritus—Tamoxifen—breast cancer	0.000396	0.00268	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Thiotepa—breast cancer	0.000394	0.00267	CcSEcCtD
Phenazopyridine—Diarrhoea—Vinblastine—breast cancer	0.000394	0.00267	CcSEcCtD
Phenazopyridine—Hypersensitivity—Goserelin—breast cancer	0.000393	0.00267	CcSEcCtD
Phenazopyridine—Pruritus—Melphalan—breast cancer	0.000387	0.00263	CcSEcCtD
Phenazopyridine—Hepatitis—Docetaxel—breast cancer	0.000384	0.0026	CcSEcCtD
Phenazopyridine—Diarrhoea—Tamoxifen—breast cancer	0.000383	0.00259	CcSEcCtD
Phenazopyridine—Pruritus—Goserelin—breast cancer	0.000378	0.00256	CcSEcCtD
Phenazopyridine—Diarrhoea—Melphalan—breast cancer	0.000375	0.00254	CcSEcCtD
Phenazopyridine—Nausea—Chlorambucil—breast cancer	0.000373	0.00253	CcSEcCtD
Phenazopyridine—Hepatitis—Capecitabine—breast cancer	0.000372	0.00252	CcSEcCtD
Phenazopyridine—Visual impairment—Docetaxel—breast cancer	0.00037	0.00251	CcSEcCtD
Phenazopyridine—Vomiting—Vinblastine—breast cancer	0.000366	0.00248	CcSEcCtD
Phenazopyridine—Diarrhoea—Goserelin—breast cancer	0.000365	0.00248	CcSEcCtD
Phenazopyridine—Headache—Vinblastine—breast cancer	0.000361	0.00245	CcSEcCtD
Phenazopyridine—Visual impairment—Capecitabine—breast cancer	0.000358	0.00243	CcSEcCtD
Phenazopyridine—Vomiting—Tamoxifen—breast cancer	0.000355	0.00241	CcSEcCtD
Phenazopyridine—Rash—Tamoxifen—breast cancer	0.000352	0.00239	CcSEcCtD
Phenazopyridine—Hypersensitivity—Vinorelbine—breast cancer	0.000352	0.00239	CcSEcCtD
Phenazopyridine—Dermatitis—Tamoxifen—breast cancer	0.000352	0.00239	CcSEcCtD
Phenazopyridine—Headache—Tamoxifen—breast cancer	0.00035	0.00238	CcSEcCtD
Phenazopyridine—Vomiting—Melphalan—breast cancer	0.000348	0.00236	CcSEcCtD
Phenazopyridine—Dyspepsia—Mitoxantrone—breast cancer	0.000347	0.00235	CcSEcCtD
Phenazopyridine—Dyspepsia—Irinotecan—breast cancer	0.000347	0.00235	CcSEcCtD
Phenazopyridine—Rash—Melphalan—breast cancer	0.000345	0.00234	CcSEcCtD
Phenazopyridine—Dermatitis—Melphalan—breast cancer	0.000345	0.00234	CcSEcCtD
Phenazopyridine—Nausea—Vinblastine—breast cancer	0.000342	0.00232	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Irinotecan—breast cancer	0.000341	0.00231	CcSEcCtD
Phenazopyridine—Vomiting—Goserelin—breast cancer	0.00034	0.0023	CcSEcCtD
Phenazopyridine—Pruritus—Vinorelbine—breast cancer	0.000338	0.00229	CcSEcCtD
Phenazopyridine—Rash—Goserelin—breast cancer	0.000337	0.00228	CcSEcCtD
Phenazopyridine—Hypersensitivity—Thiotepa—breast cancer	0.000336	0.00228	CcSEcCtD
Phenazopyridine—Dermatitis—Goserelin—breast cancer	0.000336	0.00228	CcSEcCtD
Phenazopyridine—Headache—Goserelin—breast cancer	0.000335	0.00227	CcSEcCtD
Phenazopyridine—Dyspepsia—Fluorouracil—breast cancer	0.000333	0.00226	CcSEcCtD
Phenazopyridine—Nausea—Tamoxifen—breast cancer	0.000332	0.00225	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000332	0.00225	CcSEcCtD
Phenazopyridine—Diarrhoea—Vinorelbine—breast cancer	0.000327	0.00222	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000326	0.00221	CcSEcCtD
Phenazopyridine—Nausea—Melphalan—breast cancer	0.000325	0.00221	CcSEcCtD
Phenazopyridine—Pruritus—Thiotepa—breast cancer	0.000323	0.00219	CcSEcCtD
Phenazopyridine—Nausea—Goserelin—breast cancer	0.000317	0.00215	CcSEcCtD
Phenazopyridine—Diarrhoea—Thiotepa—breast cancer	0.000312	0.00212	CcSEcCtD
Phenazopyridine—Vomiting—Vinorelbine—breast cancer	0.000304	0.00206	CcSEcCtD
Phenazopyridine—Rash—Vinorelbine—breast cancer	0.000302	0.00205	CcSEcCtD
Phenazopyridine—Dermatitis—Vinorelbine—breast cancer	0.000301	0.00204	CcSEcCtD
Phenazopyridine—Headache—Vinorelbine—breast cancer	0.0003	0.00203	CcSEcCtD
Phenazopyridine—Hypersensitivity—Mitoxantrone—breast cancer	0.000291	0.00197	CcSEcCtD
Phenazopyridine—Hypersensitivity—Irinotecan—breast cancer	0.000291	0.00197	CcSEcCtD
Phenazopyridine—Vomiting—Thiotepa—breast cancer	0.00029	0.00197	CcSEcCtD
Phenazopyridine—Rash—Thiotepa—breast cancer	0.000288	0.00195	CcSEcCtD
Phenazopyridine—Dermatitis—Thiotepa—breast cancer	0.000288	0.00195	CcSEcCtD
Phenazopyridine—Headache—Thiotepa—breast cancer	0.000286	0.00194	CcSEcCtD
Phenazopyridine—Nausea—Vinorelbine—breast cancer	0.000284	0.00193	CcSEcCtD
Phenazopyridine—Dyspepsia—Paclitaxel—breast cancer	0.000283	0.00192	CcSEcCtD
Phenazopyridine—Jaundice—Epirubicin—breast cancer	0.000281	0.00191	CcSEcCtD
Phenazopyridine—Hypersensitivity—Fluorouracil—breast cancer	0.000278	0.00189	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000278	0.00188	CcSEcCtD
Phenazopyridine—Hepatitis—Methotrexate—breast cancer	0.000277	0.00188	CcSEcCtD
Phenazopyridine—Pruritus—Gemcitabine—breast cancer	0.000272	0.00184	CcSEcCtD
Phenazopyridine—Nausea—Thiotepa—breast cancer	0.000271	0.00184	CcSEcCtD
Phenazopyridine—Diarrhoea—Mitoxantrone—breast cancer	0.00027	0.00183	CcSEcCtD
Phenazopyridine—Diarrhoea—Irinotecan—breast cancer	0.00027	0.00183	CcSEcCtD
Phenazopyridine—Pruritus—Fluorouracil—breast cancer	0.000267	0.00181	CcSEcCtD
Phenazopyridine—Visual impairment—Methotrexate—breast cancer	0.000267	0.00181	CcSEcCtD
Phenazopyridine—Diarrhoea—Gemcitabine—breast cancer	0.000263	0.00178	CcSEcCtD
Phenazopyridine—Jaundice—Doxorubicin—breast cancer	0.00026	0.00176	CcSEcCtD
Phenazopyridine—Hepatitis—Epirubicin—breast cancer	0.000259	0.00176	CcSEcCtD
Phenazopyridine—Diarrhoea—Fluorouracil—breast cancer	0.000258	0.00175	CcSEcCtD
Phenazopyridine—Vomiting—Mitoxantrone—breast cancer	0.000251	0.0017	CcSEcCtD
Phenazopyridine—Vomiting—Irinotecan—breast cancer	0.000251	0.0017	CcSEcCtD
Phenazopyridine—Visual impairment—Epirubicin—breast cancer	0.000249	0.00169	CcSEcCtD
Phenazopyridine—Rash—Irinotecan—breast cancer	0.000249	0.00169	CcSEcCtD
Phenazopyridine—Rash—Mitoxantrone—breast cancer	0.000249	0.00169	CcSEcCtD
Phenazopyridine—Dermatitis—Irinotecan—breast cancer	0.000248	0.00169	CcSEcCtD
Phenazopyridine—Dermatitis—Mitoxantrone—breast cancer	0.000248	0.00169	CcSEcCtD
Phenazopyridine—Headache—Mitoxantrone—breast cancer	0.000247	0.00168	CcSEcCtD
Phenazopyridine—Headache—Irinotecan—breast cancer	0.000247	0.00168	CcSEcCtD
Phenazopyridine—Vomiting—Gemcitabine—breast cancer	0.000244	0.00166	CcSEcCtD
Phenazopyridine—Rash—Gemcitabine—breast cancer	0.000242	0.00164	CcSEcCtD
Phenazopyridine—Dermatitis—Gemcitabine—breast cancer	0.000242	0.00164	CcSEcCtD
Phenazopyridine—Headache—Gemcitabine—breast cancer	0.000241	0.00163	CcSEcCtD
Phenazopyridine—Vomiting—Fluorouracil—breast cancer	0.00024	0.00163	CcSEcCtD
Phenazopyridine—Dyspepsia—Docetaxel—breast cancer	0.00024	0.00163	CcSEcCtD
Phenazopyridine—Hepatitis—Doxorubicin—breast cancer	0.00024	0.00162	CcSEcCtD
Phenazopyridine—Rash—Fluorouracil—breast cancer	0.000238	0.00162	CcSEcCtD
Phenazopyridine—Dermatitis—Fluorouracil—breast cancer	0.000238	0.00161	CcSEcCtD
Phenazopyridine—Hypersensitivity—Paclitaxel—breast cancer	0.000237	0.00161	CcSEcCtD
Phenazopyridine—Headache—Fluorouracil—breast cancer	0.000237	0.00161	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Docetaxel—breast cancer	0.000235	0.0016	CcSEcCtD
Phenazopyridine—Nausea—Mitoxantrone—breast cancer	0.000234	0.00159	CcSEcCtD
Phenazopyridine—Nausea—Irinotecan—breast cancer	0.000234	0.00159	CcSEcCtD
Phenazopyridine—Dyspepsia—Capecitabine—breast cancer	0.000232	0.00158	CcSEcCtD
Phenazopyridine—Visual impairment—Doxorubicin—breast cancer	0.000231	0.00157	CcSEcCtD
Phenazopyridine—Nausea—Gemcitabine—breast cancer	0.000228	0.00155	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Capecitabine—breast cancer	0.000228	0.00155	CcSEcCtD
Phenazopyridine—Pruritus—Paclitaxel—breast cancer	0.000228	0.00154	CcSEcCtD
Phenazopyridine—Nausea—Fluorouracil—breast cancer	0.000224	0.00152	CcSEcCtD
Phenazopyridine—Diarrhoea—Paclitaxel—breast cancer	0.00022	0.00149	CcSEcCtD
Phenazopyridine—Vomiting—Paclitaxel—breast cancer	0.000205	0.00139	CcSEcCtD
Phenazopyridine—Rash—Paclitaxel—breast cancer	0.000203	0.00138	CcSEcCtD
Phenazopyridine—Dermatitis—Paclitaxel—breast cancer	0.000203	0.00137	CcSEcCtD
Phenazopyridine—Headache—Paclitaxel—breast cancer	0.000202	0.00137	CcSEcCtD
Phenazopyridine—Hypersensitivity—Docetaxel—breast cancer	0.000201	0.00136	CcSEcCtD
Phenazopyridine—Hypersensitivity—Capecitabine—breast cancer	0.000194	0.00132	CcSEcCtD
Phenazopyridine—Pruritus—Docetaxel—breast cancer	0.000193	0.00131	CcSEcCtD
Phenazopyridine—Nausea—Paclitaxel—breast cancer	0.000191	0.0013	CcSEcCtD
Phenazopyridine—Pruritus—Capecitabine—breast cancer	0.000187	0.00127	CcSEcCtD
Phenazopyridine—Diarrhoea—Docetaxel—breast cancer	0.000187	0.00127	CcSEcCtD
Phenazopyridine—Diarrhoea—Capecitabine—breast cancer	0.000181	0.00123	CcSEcCtD
Phenazopyridine—Vomiting—Docetaxel—breast cancer	0.000173	0.00118	CcSEcCtD
Phenazopyridine—Dyspepsia—Methotrexate—breast cancer	0.000173	0.00117	CcSEcCtD
Phenazopyridine—Rash—Docetaxel—breast cancer	0.000172	0.00117	CcSEcCtD
Phenazopyridine—Dermatitis—Docetaxel—breast cancer	0.000172	0.00116	CcSEcCtD
Phenazopyridine—Headache—Docetaxel—breast cancer	0.000171	0.00116	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Methotrexate—breast cancer	0.00017	0.00115	CcSEcCtD
Phenazopyridine—Vomiting—Capecitabine—breast cancer	0.000168	0.00114	CcSEcCtD
Phenazopyridine—Rash—Capecitabine—breast cancer	0.000166	0.00113	CcSEcCtD
Phenazopyridine—Dermatitis—Capecitabine—breast cancer	0.000166	0.00113	CcSEcCtD
Phenazopyridine—Headache—Capecitabine—breast cancer	0.000165	0.00112	CcSEcCtD
Phenazopyridine—Nausea—Docetaxel—breast cancer	0.000162	0.0011	CcSEcCtD
Phenazopyridine—Dyspepsia—Epirubicin—breast cancer	0.000162	0.0011	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Epirubicin—breast cancer	0.000159	0.00108	CcSEcCtD
Phenazopyridine—Nausea—Capecitabine—breast cancer	0.000157	0.00106	CcSEcCtD
Phenazopyridine—Dyspepsia—Doxorubicin—breast cancer	0.00015	0.00102	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000147	0.000996	CcSEcCtD
Phenazopyridine—Hypersensitivity—Methotrexate—breast cancer	0.000145	0.000982	CcSEcCtD
Phenazopyridine—Pruritus—Methotrexate—breast cancer	0.000139	0.000943	CcSEcCtD
Phenazopyridine—Hypersensitivity—Epirubicin—breast cancer	0.000135	0.000919	CcSEcCtD
Phenazopyridine—Diarrhoea—Methotrexate—breast cancer	0.000134	0.000912	CcSEcCtD
Phenazopyridine—Pruritus—Epirubicin—breast cancer	0.00013	0.000882	CcSEcCtD
Phenazopyridine—Diarrhoea—Epirubicin—breast cancer	0.000126	0.000853	CcSEcCtD
Phenazopyridine—Hypersensitivity—Doxorubicin—breast cancer	0.000125	0.00085	CcSEcCtD
Phenazopyridine—Vomiting—Methotrexate—breast cancer	0.000125	0.000847	CcSEcCtD
Phenazopyridine—Rash—Methotrexate—breast cancer	0.000124	0.00084	CcSEcCtD
Phenazopyridine—Dermatitis—Methotrexate—breast cancer	0.000124	0.00084	CcSEcCtD
Phenazopyridine—Headache—Methotrexate—breast cancer	0.000123	0.000835	CcSEcCtD
Phenazopyridine—Pruritus—Doxorubicin—breast cancer	0.00012	0.000817	CcSEcCtD
Phenazopyridine—Vomiting—Epirubicin—breast cancer	0.000117	0.000793	CcSEcCtD
Phenazopyridine—Nausea—Methotrexate—breast cancer	0.000117	0.000792	CcSEcCtD
Phenazopyridine—Diarrhoea—Doxorubicin—breast cancer	0.000116	0.00079	CcSEcCtD
Phenazopyridine—Rash—Epirubicin—breast cancer	0.000116	0.000786	CcSEcCtD
Phenazopyridine—Dermatitis—Epirubicin—breast cancer	0.000116	0.000786	CcSEcCtD
Phenazopyridine—Headache—Epirubicin—breast cancer	0.000115	0.000781	CcSEcCtD
Phenazopyridine—Nausea—Epirubicin—breast cancer	0.000109	0.000741	CcSEcCtD
Phenazopyridine—Vomiting—Doxorubicin—breast cancer	0.000108	0.000734	CcSEcCtD
Phenazopyridine—Rash—Doxorubicin—breast cancer	0.000107	0.000728	CcSEcCtD
Phenazopyridine—Dermatitis—Doxorubicin—breast cancer	0.000107	0.000727	CcSEcCtD
Phenazopyridine—Headache—Doxorubicin—breast cancer	0.000107	0.000723	CcSEcCtD
Phenazopyridine—Nausea—Doxorubicin—breast cancer	0.000101	0.000686	CcSEcCtD
Phenazopyridine—SCN1A—Developmental Biology—MET—breast cancer	4.71e-05	0.00027	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MET—breast cancer	4.71e-05	0.00027	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—NOTCH1—breast cancer	4.71e-05	0.000269	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—NOTCH1—breast cancer	4.71e-05	0.000269	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—VEGFA—breast cancer	4.69e-05	0.000269	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—MMP9—breast cancer	4.67e-05	0.000268	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—EGFR—breast cancer	4.67e-05	0.000267	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—SRC—breast cancer	4.66e-05	0.000267	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MET—breast cancer	4.64e-05	0.000266	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—HRAS—breast cancer	4.6e-05	0.000263	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—CTNNB1—breast cancer	4.6e-05	0.000263	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—AKT2—breast cancer	4.58e-05	0.000262	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—VEGFA—breast cancer	4.54e-05	0.00026	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—NOTCH1—breast cancer	4.54e-05	0.00026	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—NOTCH1—breast cancer	4.54e-05	0.00026	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MMP9—breast cancer	4.51e-05	0.000258	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—STAT3—breast cancer	4.5e-05	0.000258	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—MMP9—breast cancer	4.47e-05	0.000256	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ABL1—breast cancer	4.47e-05	0.000256	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MMP2—breast cancer	4.44e-05	0.000254	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—KRAS—breast cancer	4.41e-05	0.000253	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—IL6—breast cancer	4.4e-05	0.000252	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—AKT2—breast cancer	4.38e-05	0.000251	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SMAD4—breast cancer	4.33e-05	0.000248	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—SRC—breast cancer	4.31e-05	0.000247	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—MAPK3—breast cancer	4.3e-05	0.000246	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—MMP9—breast cancer	4.3e-05	0.000246	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—MMP9—breast cancer	4.3e-05	0.000246	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MMP2—breast cancer	4.24e-05	0.000243	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—HES1—breast cancer	4.23e-05	0.000242	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—AKT2—breast cancer	4.21e-05	0.000241	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—AKT2—breast cancer	4.21e-05	0.000241	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—CTNNB1—breast cancer	4.21e-05	0.000241	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—NCOR1—breast cancer	4.2e-05	0.000241	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—VEGFA—breast cancer	4.2e-05	0.00024	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—TGFB1—breast cancer	4.17e-05	0.000239	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—SRC—breast cancer	4.16e-05	0.000238	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—MMP9—breast cancer	4.14e-05	0.000237	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—MMP9—breast cancer	4.14e-05	0.000237	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—MMP9—breast cancer	4.12e-05	0.000236	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—SRC—breast cancer	4.12e-05	0.000236	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—HRAS—breast cancer	4.1e-05	0.000235	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—EGFR—breast cancer	4.09e-05	0.000234	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MMP2—breast cancer	4.08e-05	0.000233	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MMP2—breast cancer	4.08e-05	0.000233	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—AKT2—breast cancer	4.06e-05	0.000232	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—AKT2—breast cancer	4.06e-05	0.000232	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—VEGFA—breast cancer	4.05e-05	0.000232	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—TNF—breast cancer	4.02e-05	0.00023	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—VEGFA—breast cancer	4.01e-05	0.00023	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—STAT3—breast cancer	4.01e-05	0.00023	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—MAPK3—breast cancer	3.97e-05	0.000227	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—SRC—breast cancer	3.96e-05	0.000227	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—SRC—breast cancer	3.96e-05	0.000227	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MMP2—breast cancer	3.93e-05	0.000225	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MMP2—breast cancer	3.93e-05	0.000225	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—RAF1—breast cancer	3.93e-05	0.000225	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—IL6—breast cancer	3.92e-05	0.000225	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—RELA—breast cancer	3.91e-05	0.000224	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—TNF—breast cancer	3.89e-05	0.000223	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—ERBB2—breast cancer	3.89e-05	0.000223	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MMP2—breast cancer	3.87e-05	0.000222	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—KRAS—breast cancer	3.86e-05	0.000221	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—VEGFA—breast cancer	3.86e-05	0.000221	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—VEGFA—breast cancer	3.86e-05	0.000221	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MAPK3—breast cancer	3.83e-05	0.000219	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—SRC—breast cancer	3.82e-05	0.000219	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—SRC—breast cancer	3.82e-05	0.000219	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—SRC—breast cancer	3.8e-05	0.000218	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—MAPK3—breast cancer	3.8e-05	0.000217	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—EGFR—breast cancer	3.78e-05	0.000216	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—RAF1—breast cancer	3.76e-05	0.000215	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—HRAS—breast cancer	3.75e-05	0.000215	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—RELA—breast cancer	3.74e-05	0.000214	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—ERBB2—breast cancer	3.72e-05	0.000213	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—VEGFA—breast cancer	3.72e-05	0.000213	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—VEGFA—breast cancer	3.72e-05	0.000213	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TGFB1—breast cancer	3.72e-05	0.000213	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—VEGFA—breast cancer	3.7e-05	0.000212	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—STAT3—breast cancer	3.67e-05	0.00021	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—MAPK3—breast cancer	3.65e-05	0.000209	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—MAPK3—breast cancer	3.65e-05	0.000209	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—EGFR—breast cancer	3.64e-05	0.000209	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—EGFR—breast cancer	3.61e-05	0.000207	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—RAF1—breast cancer	3.61e-05	0.000207	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—RAF1—breast cancer	3.61e-05	0.000207	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—RELA—breast cancer	3.6e-05	0.000206	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—RELA—breast cancer	3.6e-05	0.000206	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—FGFR1—breast cancer	3.6e-05	0.000206	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—IL6—breast cancer	3.59e-05	0.000205	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—ERBB2—breast cancer	3.57e-05	0.000205	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—ERBB2—breast cancer	3.57e-05	0.000205	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—KRAS—breast cancer	3.57e-05	0.000204	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—MAPK3—breast cancer	3.52e-05	0.000201	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—MAPK3—breast cancer	3.52e-05	0.000201	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—MAPK3—breast cancer	3.5e-05	0.000201	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—RAF1—breast cancer	3.48e-05	0.000199	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—RAF1—breast cancer	3.48e-05	0.000199	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—EGFR—breast cancer	3.47e-05	0.000199	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—EGFR—breast cancer	3.47e-05	0.000199	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TNF—breast cancer	3.47e-05	0.000199	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—RELA—breast cancer	3.47e-05	0.000199	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—RELA—breast cancer	3.47e-05	0.000199	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—LEP—breast cancer	3.46e-05	0.000198	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—ERBB2—breast cancer	3.45e-05	0.000197	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—ERBB2—breast cancer	3.45e-05	0.000197	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—KRAS—breast cancer	3.44e-05	0.000197	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—RAF1—breast cancer	3.43e-05	0.000196	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—KRAS—breast cancer	3.41e-05	0.000195	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—CTNNB1—breast cancer	3.4e-05	0.000195	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TGFB1—breast cancer	3.4e-05	0.000195	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—ERBB2—breast cancer	3.39e-05	0.000194	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—KDR—breast cancer	3.39e-05	0.000194	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—EGFR—breast cancer	3.35e-05	0.000192	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—EGFR—breast cancer	3.35e-05	0.000192	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MMP9—breast cancer	3.34e-05	0.000191	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—EGFR—breast cancer	3.33e-05	0.000191	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CDK4—breast cancer	3.31e-05	0.00019	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MET—breast cancer	3.31e-05	0.00019	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—HRAS—breast cancer	3.28e-05	0.000188	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—KRAS—breast cancer	3.28e-05	0.000188	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—KRAS—breast cancer	3.28e-05	0.000188	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—CTNNB1—breast cancer	3.25e-05	0.000186	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—IL6—breast cancer	3.25e-05	0.000186	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MMP9—breast cancer	3.19e-05	0.000183	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—NOTCH1—breast cancer	3.19e-05	0.000183	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TNF—breast cancer	3.17e-05	0.000182	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—KRAS—breast cancer	3.16e-05	0.000181	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—KRAS—breast cancer	3.16e-05	0.000181	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—KRAS—breast cancer	3.15e-05	0.00018	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—IL6—breast cancer	3.14e-05	0.00018	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CTNNB1—breast cancer	3.13e-05	0.000179	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CTNNB1—breast cancer	3.13e-05	0.000179	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—SRC—breast cancer	3.08e-05	0.000176	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MMP9—breast cancer	3.07e-05	0.000175	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MMP9—breast cancer	3.07e-05	0.000175	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—HRAS—breast cancer	3.03e-05	0.000174	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CTNNB1—breast cancer	3.01e-05	0.000173	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—CTNNB1—breast cancer	3.01e-05	0.000173	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—VEGFA—breast cancer	3e-05	0.000171	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—STAT3—breast cancer	2.97e-05	0.00017	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MMP9—breast cancer	2.96e-05	0.000169	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MMP9—breast cancer	2.96e-05	0.000169	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—SRC—breast cancer	2.94e-05	0.000168	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—HRAS—breast cancer	2.93e-05	0.000168	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MMP9—breast cancer	2.91e-05	0.000167	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—IL6—breast cancer	2.9e-05	0.000166	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—HRAS—breast cancer	2.9e-05	0.000166	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—AKT1—breast cancer	2.9e-05	0.000166	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—VEGFA—breast cancer	2.86e-05	0.000164	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—AKT2—breast cancer	2.85e-05	0.000163	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—STAT3—breast cancer	2.84e-05	0.000162	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MAPK3—breast cancer	2.83e-05	0.000162	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—SRC—breast cancer	2.83e-05	0.000162	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—SRC—breast cancer	2.83e-05	0.000162	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—IL6—breast cancer	2.8e-05	0.00016	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—HRAS—breast cancer	2.79e-05	0.00016	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—HRAS—breast cancer	2.79e-05	0.00016	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—IL6—breast cancer	2.78e-05	0.000159	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MMP2—breast cancer	2.76e-05	0.000158	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—VEGFA—breast cancer	2.75e-05	0.000158	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—VEGFA—breast cancer	2.75e-05	0.000158	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—TGFB1—breast cancer	2.75e-05	0.000157	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—STAT3—breast cancer	2.73e-05	0.000156	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—STAT3—breast cancer	2.73e-05	0.000156	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—SRC—breast cancer	2.72e-05	0.000156	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—SRC—breast cancer	2.72e-05	0.000156	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MAPK3—breast cancer	2.71e-05	0.000155	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—EGFR—breast cancer	2.7e-05	0.000154	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—HRAS—breast cancer	2.69e-05	0.000154	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—HRAS—breast cancer	2.69e-05	0.000154	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—SRC—breast cancer	2.68e-05	0.000154	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—HRAS—breast cancer	2.68e-05	0.000153	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—IL6—breast cancer	2.67e-05	0.000153	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—IL6—breast cancer	2.67e-05	0.000153	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—VEGFA—breast cancer	2.65e-05	0.000152	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—VEGFA—breast cancer	2.65e-05	0.000152	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—TGFB1—breast cancer	2.63e-05	0.000151	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—STAT3—breast cancer	2.63e-05	0.00015	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—STAT3—breast cancer	2.63e-05	0.00015	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—VEGFA—breast cancer	2.61e-05	0.00015	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MAPK3—breast cancer	2.6e-05	0.000149	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MAPK3—breast cancer	2.6e-05	0.000149	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—AKT1—breast cancer	2.58e-05	0.000148	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—EGFR—breast cancer	2.58e-05	0.000148	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—IL6—breast cancer	2.57e-05	0.000147	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—IL6—breast cancer	2.57e-05	0.000147	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—TNF—breast cancer	2.57e-05	0.000147	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—IL6—breast cancer	2.56e-05	0.000147	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—KRAS—breast cancer	2.55e-05	0.000146	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TGFB1—breast cancer	2.53e-05	0.000145	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TGFB1—breast cancer	2.53e-05	0.000145	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MAPK3—breast cancer	2.51e-05	0.000144	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MAPK3—breast cancer	2.51e-05	0.000144	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—EGFR—breast cancer	2.48e-05	0.000142	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—EGFR—breast cancer	2.48e-05	0.000142	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MAPK3—breast cancer	2.47e-05	0.000142	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—TNF—breast cancer	2.46e-05	0.000141	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—RAF1—breast cancer	2.45e-05	0.00014	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—RELA—breast cancer	2.44e-05	0.00014	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—TGFB1—breast cancer	2.44e-05	0.000139	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TGFB1—breast cancer	2.44e-05	0.000139	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—KRAS—breast cancer	2.44e-05	0.000139	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ERBB2—breast cancer	2.42e-05	0.000139	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—EGFR—breast cancer	2.39e-05	0.000137	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—EGFR—breast cancer	2.39e-05	0.000137	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—AKT1—breast cancer	2.36e-05	0.000135	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TNF—breast cancer	2.36e-05	0.000135	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TNF—breast cancer	2.36e-05	0.000135	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—EGFR—breast cancer	2.35e-05	0.000135	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—KRAS—breast cancer	2.34e-05	0.000134	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—KRAS—breast cancer	2.34e-05	0.000134	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TNF—breast cancer	2.27e-05	0.00013	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—TNF—breast cancer	2.27e-05	0.00013	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—KRAS—breast cancer	2.26e-05	0.000129	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—KRAS—breast cancer	2.26e-05	0.000129	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—KRAS—breast cancer	2.22e-05	0.000127	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—HRAS—breast cancer	2.16e-05	0.000124	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CTNNB1—breast cancer	2.12e-05	0.000121	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MMP9—breast cancer	2.08e-05	0.000119	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—IL6—breast cancer	2.07e-05	0.000119	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—HRAS—breast cancer	2.07e-05	0.000119	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—HRAS—breast cancer	1.99e-05	0.000114	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—HRAS—breast cancer	1.99e-05	0.000114	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—IL6—breast cancer	1.98e-05	0.000113	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—HRAS—breast cancer	1.92e-05	0.00011	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—HRAS—breast cancer	1.92e-05	0.00011	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SRC—breast cancer	1.92e-05	0.00011	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—AKT1—breast cancer	1.91e-05	0.000109	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—IL6—breast cancer	1.9e-05	0.000109	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—IL6—breast cancer	1.9e-05	0.000109	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—HRAS—breast cancer	1.89e-05	0.000108	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—VEGFA—breast cancer	1.87e-05	0.000107	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—STAT3—breast cancer	1.85e-05	0.000106	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—IL6—breast cancer	1.84e-05	0.000105	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—IL6—breast cancer	1.84e-05	0.000105	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—AKT1—breast cancer	1.83e-05	0.000105	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—IL6—breast cancer	1.81e-05	0.000104	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MAPK3—breast cancer	1.77e-05	0.000101	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—AKT1—breast cancer	1.76e-05	0.000101	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—AKT1—breast cancer	1.76e-05	0.000101	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TGFB1—breast cancer	1.71e-05	9.8e-05	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—AKT1—breast cancer	1.69e-05	9.69e-05	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—AKT1—breast cancer	1.69e-05	9.69e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—EGFR—breast cancer	1.68e-05	9.61e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TNF—breast cancer	1.6e-05	9.15e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—KRAS—breast cancer	1.59e-05	9.08e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—HRAS—breast cancer	1.35e-05	7.72e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—IL6—breast cancer	1.29e-05	7.39e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—AKT1—breast cancer	1.19e-05	6.82e-05	CbGpPWpGaD
